NCT06610071Not yet recruitingPhase 1
NIFR Image-guided Surgery for Malignant Soft Tissue Tumor With Low-dose SWIG Technique
Near-infrared Fluorescence Image-guided Surgery for Malignant Soft Tissue Tumor With Low-dose Second Window Indocyanine Green Technique: a Multicenter Randomized Controlled Trial
Source: ClinicalTrials.gov · Last updated 24 Sept 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This research study will evaluate how near-infrared fluorescence (NIRF) imaging with low-dose second window indocyanine green (ICG) can assist in the radical resection and pathologic diagnosis of malignant soft tissue sarcoma, such as dermatofibrosarcoma protuberans (DFSP) and skin squamous cell carcinoma (sSCC) during surgery.
- Status (registry)
- Not yet recruiting
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 592 (estimated)
- First submitted
- 1 Sept 2024
- Start date
- 30 Oct 2024
- Primary completion date
- Dec 2028
- Lead sponsor
- The Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
- Diseases
- Childhood cancers, Sarcoma
- NCT number
- NCT06610071
What you commit to
- Study type: Interventional · Phase 1
- Planned participants: 592
- From 30 Oct 2024 to the primary completion date, Dec 2028
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- seafood/iodine allergy
- acute severe hypertension
Other
- hyperthyroidism
- pregnancy
- myasthenia gravis
Who the study is looking for
- Patients with DFSPs or sSCC in heads, extremities or trunk
Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.